Skip to main content
SpringerLink
Log in

Apoprotein Measurements

  • Chapter
Drugs Affecting Lipid Metabolism VIII

  • 69 Accesses

Abstract

The development and application of methods of measuring apoproteins have significantly increased our knowledge of apoprotein and lipoprotein structure and metabolism, resulting in a dramatic increase in our understanding of the physiology and pathophysiology of lipoproteins. The apoproteins are not only essential structural components of the lipoproteins but also play an important role in the regulation of lipoprotein metabolism through their function as ligands for cellular receptors and cofactors of lipolytic enzymes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J. D. Brunzell, J. J. Albers, Alan Chait, S. M. Grundy, E. Groszek, and G. B. McDonald, Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia, J. Lipid Res. 24: 147 – 155 (1983).

    PubMed  CAS  Google Scholar 

  2. R. S. Kushwaha, W. R. Hazzard, P. W. Wahl, and J. J. Hover, Type 3 hyperlipoproteinemia - diagnosis on whole plasma by apolipo- protein-E immunoassay, Ann. Int. Med. 87: 509 – 516 (1977).

    PubMed  CAS  Google Scholar 

  3. E. J. Schaefer, L. L. Kay, L. A. Zech, and H. B. Brewer, Jr., Tangier Disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-I (APOA-ITangier), J. Clin. Invest. 70: 934 – 945 (1982).

    Article  PubMed  CAS  Google Scholar 

  4. K. H. Weisgraber, S. C. Rail, Jr., T. P. Bersot, R. W. Mahley, G. Franceschini, and C. R. Sirtori, Apolipoprotein A-I Milano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I, J. Biol. Chem. 258: 2508 – 2513 (1983).

    PubMed  CAS  Google Scholar 

  5. G. Utermann, M. Jaeschke, and J. Mangel, Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins, FEBS Lett. 56: 352 – 355 (1975).

    Article  PubMed  CAS  Google Scholar 

  6. K. H. Weisgraber, S. C. Rail, Jr., and R. W. Mahley, Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the amino acid sequence of the apo-E isoforms, J. Biol. Chem. 256: 9077 – 9083 (1981).

    CAS  Google Scholar 

  7. H. M. Taggard, D. Applebaum-Bowden, S. Haffner, G. R. Warnick, M. C. Cheung, J. J. Albers, C. H. Chestnut, III, and W. R. Hazzard, Reduction in high density lipoproteins by anabolic steroid (Stanozolol) therapy for postmenopausal osteoporosis, Metabolism 31: 1147 – 1152 (1982).

    Article  Google Scholar 

  8. J. J. Albers and F. Aladjem, Precipitation of 1251-labeled lipoproteins with specific polypeptide antisera. Evidence for two populations with differing polypeptide compositions in human high density lipoproteins, Biochemistry 10: 3436 – 3442 (1971).

    Article  PubMed  CAS  Google Scholar 

  9. M. C. Cheung and J. J. Albers, Distribution of high density lipoprotein particles with different apoprotein composition: Particles with A-I and A-II and particles with A-I but no A-II, J. Lipid Res. 23: 747 – 753 (1982).

    PubMed  CAS  Google Scholar 

  10. M. J. Tikkanen, R. Dargar, B. Pfleger, B. Gonen, J. M. Davie, and G. Schonfeld, Antigenic mapping of human low densitylipoprotein with monoclonal antibodies, J. Lip. Res. 23: 1032 – 1038 (1982).

    CAS  Google Scholar 

  11. Y. L. Marcel, M. Hogue, R. Theolis, Jr., and R. W. Milne, Mapping of antigenic determinants of human apolipoprotein B using monoclonal antibodies against low density lipoproteins, J. Biol. Chem. 257: 13165 – 13168 (1982).

    PubMed  CAS  Google Scholar 

  12. B. P. Tsao, L. K. Curtiss, and T. S. Edgington, Immunochemical heterogeneity of human plasma apolipoprotein B: II. Expression of apolipoprotein B epitopes on native lipoproteins, J. Biol. Chem. 257: 15222 – 15228 (1982).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Northwest Lipid Research Clinic, University of Washington School of Medicine, 465 Harborview Hall, Seattle, Washington, 98104, USA

    John J. Albers

Authors
  1. John J. Albers
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania, USA

    David Kritchevsky

  2. West Chester, Pennsylvania, USA

    William L. Holmes

  3. Institute of Pharmacology and Pharmacognosy, University of Milan, Milan, Italy

    Rodolfo Paoletti

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Plenum Press, New York

About this chapter

Cite this chapter

Albers, J.J. (1985). Apoprotein Measurements. In: Kritchevsky, D., Holmes, W.L., Paoletti, R. (eds) Drugs Affecting Lipid Metabolism VIII. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2459-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2459-1_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9493-1

  • Online ISBN: 978-1-4613-2459-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation